ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma

Clinical trial NCT04904185 · TERMINATED

Trial details

NCT number: NCT04904185
Sponsor: Inge Marie Svane
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2021-09-17
Primary completion: 2024-06-07
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.